Stonepine Capital Management, LLC Veracyte, Inc. Transaction History

Stonepine Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.39 - $9.66 $4.17 Million - $7.48 Million	-773,889 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$5.44 - $6.97 $2.51 Million - $3.21 Million	-461,258 Reduced 37.34%	773,889 $4.3 Million
Q4 2017 Feb 13, 2018	BUY	$6.05 - $9.37 $5.48 Million - $8.48 Million	905,147 Added 274.29%	1,235,147 $8.07 Million
Q3 2017 Nov 13, 2017	SELL	$7.81 - $8.77 $4.18 Million - $4.69 Million	-534,695 Reduced 61.84%	330,000 $2.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	864,695	864,695 $7.2 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.